Overexpression USP22 is a marker of aggressive cancer phenotypes like metastasis, and therapy resistance studies have shown that catalyzing SAGA subunit USP22 to control CCND1 ubiquitination is important for the progression of cancer cells through the G1 cell cycle [128]. This evidence concerns the gene CCND1 and cancer.